Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

  1. Pascual, T.
  2. Oliveira, M.
  3. Villagrasa, P.
  4. Ortega, V.
  5. Paré, L.
  6. Bermejo, B.
  7. Morales, S.
  8. Amillano, K.
  9. López, R.
  10. Galván, P.
  11. Canes, J.
  12. Salvador, F.
  13. Nuciforo, P.
  14. Rubio, I.T.
  15. Llombart-Cussac, A.
  16. Di Cosimo, S.
  17. Baselga, J.
  18. Harbeck, N.
  19. Prat, A.
  20. Cortés, J.
Journal:
npj Breast Cancer

ISSN: 2374-4677

Year of publication: 2021

Volume: 7

Issue: 1

Type: Article

DOI: 10.1038/S41523-021-00351-4 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus